Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
Clinical trial NCT03250832 · COMPLETED
Trial details
- NCT number
- NCT03250832
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2022-06-02
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.